These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25788161)

  • 1. A localised threat to an excellent antimalarial drug.
    Gbotosho GO; Akinola O
    Lancet Infect Dis; 2015 Jun; 15(6):623-4. PubMed ID: 25788161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Riamet: a new antimalarial for curative treatment of malaria].
    Delhaes L; Frealle E; Dutoit E; Camus D
    Med Trop (Mars); 2002; 62(5):485-7. PubMed ID: 12616938
    [No Abstract]   [Full Text] [Related]  

  • 3. Text messaging to improve adherence to malaria guidelines.
    Moonen B; Cohen JM
    Lancet; 2011 Aug; 378(9793):750-2. PubMed ID: 21820168
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating malaria in pregnant women: a pressing problem.
    Gutman J; Kachur SP
    Lancet Infect Dis; 2010 Nov; 10(11):739-40. PubMed ID: 21029982
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan.
    Depoortere E; Salvador ET; Stivanello E; Bisoffi Z; Guthmann JP
    Ann Trop Med Parasitol; 2004 Sep; 98(6):635-7. PubMed ID: 15324470
    [No Abstract]   [Full Text] [Related]  

  • 6. Artemether-lumefantrine (Coartem) for treatment of malaria.
    Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased urinary frequency: an unusual presentation of Plasmodium falciparum malaria.
    Zaki SA; Shanbag P
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):844-5. PubMed ID: 22805407
    [No Abstract]   [Full Text] [Related]  

  • 8. Falciparum--the masquerader.
    Khan A; Chaudhry AA; Khan U
    J Pak Med Assoc; 2012 Jan; 62(1):62-3. PubMed ID: 22352106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical comparative trial of co-artemether and benflumetol (two formulations) in the treatment of falciparum malaria].
    Sun ZW; Shan CQ; Li GF; Ding DB; Liu GY; Wang JY; Jiao XQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):159-61. PubMed ID: 12567694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
    Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
    Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.
    Checchi F; Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor WR; Guthmann JP
    Malar J; 2006 Jul; 5():59. PubMed ID: 16854236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.
    Ndounga M; Pembe Issamou Mayengue ; Casimiro PN; Koukouikila-Koussounda F; Bitemo M; Diassivy Matondo B; Ndounga Diakou LA; Basco LK; Ntoumi F
    Malar J; 2015 Oct; 14():423. PubMed ID: 26511848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
    Fogg C; Bajunirwe F; Piola P; Biraro S; Checchi F; Kiguli J; Namiiro P; Musabe J; Kyomugisha A; Guthmann JP
    Am J Trop Med Hyg; 2004 Nov; 71(5):525-30. PubMed ID: 15569777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo.
    de Wit M; Funk AL; Moussally K; Nkuba DA; Siddiqui R; Bil K; Piriou E; Bart A; Bahizi Bizoza P; Bousema T
    Malar J; 2016 Sep; 15(1):455. PubMed ID: 27599612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.